All Stories

  1. Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
  2. Oxidative Stress in HIV Infection and Alcohol Use: Role of Redox Signals in Modulation of Lipid Rafts and ATP-Binding Cassette Transporters
  3. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS
  4. Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS
  5. Investigation of ac-magnetic field stimulated nanoelectroporation of magneto-electric nano-drug-carrier inside CNS cells
  6. Electrochemical monitoring-on-chip (E-MoC) of HIV-infection in presence of cocaine and therapeutics
  7. Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
  8. Coupling of transient near infrared photonic with magnetic nanoparticle for potential dissipation-free biomedical application in brain
  9. Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages
  10. Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat
  11. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse
  12. Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers
  13. Editorial: HIV and Illicit Drugs of Abuse
  14. Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
  15. Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)
  16. Downregulation of host tryptophan–aspartate containing coat (TACO) gene restricts the entry and survival of Leishmania donovani in human macrophage model
  17. Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS
  18. Investigation of Neuropathogenesis in HIV-1 Clade B and C Infection Associated with IL-33 and ST2 Regulation
  19. Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue
  20. DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine
  21. HIV-1 gp120 and morphine induced oxidative stress: role in cell cycle regulation
  22. Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update
  23. HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity
  24. Drugs of Abuse in HIV infection and neurotoxicity
  25. Sustained-release nanoART formulation for the treatment of neuroAIDS
  26. Electrochemical sensing method for point-of-care cortisol detection in human immunodeficiency virus-infected patients
  27. Cell cycle checkpoints and pathogenesis of HIV-1 infection: a brief overview
  28. Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections
  29. β-Amyloid1-42, HIV-1Ba-L (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A
  30. Immunoneuropathogenesis of HIV-1 clades B and C: Role of redox expression and thiol modification
  31. Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation
  32. Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up
  33. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
  34. Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells
  35. Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)
  36. Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study
  37. Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)
  38. Inhibition of Nuclear Factor Erythroid 2-Related Factor 2 Exacerbates HIV-1 gp120-Induced Oxidative and Inflammatory Response: Role in HIV Associated Neurocognitive Disorder
  39. 2D-PAGE analysis of Taenia solium metacestode 10–30kDa antigens for the serodiagnosis of neurocysticercosis in children
  40. The role of alanine 163 in solute permeability of Leishmania major aquaglyceroporin LmAQP1
  41. Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children
  42. Evaluation of excretory secretory and 10-30 kDa antigens of Taenia solium Cysticerci by EITB assay for the diagnosis of neurocysticercosis